Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

QIAGEN-sponsored Award Granted for Pioneering Work on Viral Infections and the Cell Biology of Protein Folding

Published: Friday, April 09, 2010
Last Updated: Friday, April 09, 2010
Bookmark and Share
The Finnish scientist Ari Helenius has received the Otto-Warburg-Medal of the German Society for Biochemistry and Molecular Biology.

Today the Finnish scientist Ari Helenius has received the Otto-Warburg-Medal of the German Society for Biochemistry and Molecular Biology (GBM). The medal is considered the highest German honor for biochemists and molecular biologists.

Helenius explored how viruses change the programming of their host cells to their own benefit. In doing so he also discovered basic principles of biological “quality control” for the folding and assembly of protein molecules. QIAGEN, leading provider of sample and assay technologies, exclusively sponsors the Otto-Warburg-Medal with a grant of 25 000 Euros. Helenius received the award today in Mosbach, Germany.

Viruses proliferate by entering living cells and replicating there – generally to the disadvantage of the infected cell. Professor Ari Helenius explored the molecular processes of how influenza viruses manipulate their host cells, in particular by studying the synthesis and folding of Hemagglutinin. This protein molecule is being built into the virus membrane.

Helenius discovered that the attacked cell not only produces more Hemagglutinin and transports it to the membrane surface – it also checks it with a quality control system, which is actually in place for normal host cell proteins. Only functional proteins that are folded accurately and have the right structure will be processed by this biochemical “sorting -machine”.

Special enzymes recognize misfolded proteins and then a sugar molecule is added as an attachment to them. Proteins having this marker cannot leave the endoplasmic reticulum, the location where they have been assembled. This testing of newly synthesized proteins is of vital importance: a faulty molecular quality control can be the cause for different diseases like cystic fibrosis and diabetes. The concepts developed by Ari Helenius are now textbook knowledge.

“Ari Helenius strongly influenced the cell biological research over decades and developed innovative experimental approaches,” says Prof. Nikolaus Pfanner, president of the GBM. „The far ranging concepts he developed based on these discoveries are commonly accepted today. A better understanding of viral infections and cellular quality control established by his work could disclose new therapeutic options in medicine in the near future.”

“We are excited to see the Otto-Warburg-Medal awarded to Ari Helenius, a pioneer of science whose findings have brought substantial advance in several disciplines,” says Dr. Thomas Schweins, Vice President Marketing and Strategy at QIAGEN. „As a provider of a multitude of solutions for sample preparation and analysis of DNA, RNA and proteins we are delighted that we can support Ari Helenius with this year’s award and in his future research.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

QIAGEN Partners with Exosome Diagnostics
Molecular testing of biofluids promises unprecedented access to gene mutations, gene expression signatures and expression levels without costly, invasive tissue biopsies.
Wednesday, July 24, 2013
Qiagen Subsidiary SABiosciences Expands RT2 Profiler PCR Arrays
Now more than 100 arrays for various disease areas available
Monday, July 05, 2010
Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
iPS Cells Discover Drug Target for Muscle Disease
Researchers have designed a model that reprograms fibroblasts to the early stages of their differentiation into intact muscle cells in a step towards a therapeutic for Duchenne muscular dystrophy.
Engineered Hot Fat Implants Reduce Weight Gain
Scientists at UC Berkeley have developed a novel way to engineer the growth and expansion of energy-burning “good” fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.
Transplanted Stem Cells Can Benefit Retinal Disease Sufferers
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degeneration.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Researchers Identify Drug Candidate for Skin, Hair Regeneration
Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.
Basis for New Treatment Options for a Fatal Leukemia in Children Revealed
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!